retatrutide phase 2 trial obesity nejm 2023 Semaglutide and Cardiovascular Outcomes in without Diabetes Incretin triple agonist retatrutide (LY3437943)
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20





























